Categories
Anticancer Drugs Durvalumab Oncology Pharmacology Physiotherapy

Durvalumab (Warnings-29)

In this article we will discuss Durvalumab (Warnings-29)

In this article, we will discuss Durvalumab (Warnings-29). So, let’s get started.

Nervous system: Meningitis, encephalitis, myelitis and demyelination, myasthenic syndrome/myasthenia gravis (including exacerbation), Guillain-Barré syndrome, nerve paresis, and autoimmune neuropathy.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Discover more from PT Master Guide

Subscribe now to keep reading and get access to the full archive.

Continue reading